DAVID PLATT - 25 Oct 2024 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Issuer symbol
BIXT
Transactions as of
25 Oct 2024
Transactions value $
$2,084,250
Form type
4
Filing time
28 Oct 2024, 18:06:59 UTC
Previous filing
18 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT Preferred Other -$4.01M -14.1M -100% $0.29 0 25 Oct 2024 through NDPD Pharma F1, F2
transaction BIXT Preferred Other $6.1M +11.2M +130.03% $0.55 19.8M 25 Oct 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were returned to treasury and cancelled.
F2 The total holdings in BIXT by NDPD Pharma, Inc., an affiliate whose beneficial ownership includes Mike Sheikh, Ola Soderquist, and David Platt, were consolidated under indirect ownership in Davis Platt's filing.
F3 The shares were issued as payment for the sale of NDPD Pharma to Bioxytran